Entity Common Stock, Shares Outstanding of DMK PHARMACEUTICALS Corp from 31 Jul 2011 to 13 Nov 2023

Taxonomy & unit
dei: shares
Description
Indicate number of shares or other units outstanding of each of registrant's classes of capital or common stock or other ownership interests, if and as stated on cover of related periodic report. Where multiple classes or units exist define each class/interest by adding class of stock items such as Common Class A [Member], Common Class B [Member] or Partnership Interest [Member] onto the Instrument [Domain] of the Entity Listings, Instrument.
Summary
DMK PHARMACEUTICALS Corp quarterly Entity Common Stock, Shares Outstanding in shares history and change rate from 31 Jul 2011 to 13 Nov 2023.
  • DMK PHARMACEUTICALS Corp Entity Common Stock, Shares Outstanding for the quarter ending 13 Nov 2023 was 10,102,050, a 93% decline year-over-year.
Source SEC data
View on sec.gov
Entity Common Stock, Shares Outstanding, Quarterly (shares)
Entity Common Stock, Shares Outstanding, YoY Quarterly Change (%)

DMK PHARMACEUTICALS Corp Quarterly Entity Common Stock, Shares Outstanding (shares)

Period Value YoY Chg Change % Date Report Filed Fiscal Year Fiscal Period
Q3 2023 10,102,050 -139,881,215 -93% 13 Nov 2023 10-Q 14 Nov 2023 2023 Q3
Q1 2023 149,983,265 +250,000 +0.17% 13 Mar 2023 10-K 16 Mar 2023 2022 FY
Q3 2022 149,983,265 08 Nov 2022 10-Q 14 Nov 2022 2022 Q3
Q2 2022 149,983,265 05 Aug 2022 10-Q 10 Aug 2022 2022 Q2
Q1 2022 149,733,265 +847,124 +0.57% 25 Mar 2022 10-K 31 Mar 2022 2021 FY
Q4 2021 148,886,141 22 Nov 2021 10-Q 22 Nov 2021 2021 Q2
Q1 2021 148,886,141 +75,153,853 +102% 13 Apr 2021 10-K 15 Apr 2021 2020 FY
Q3 2020 93,657,628 +32,023,819 +52% 05 Nov 2020 10-Q 09 Nov 2020 2020 Q3
Q2 2020 73,920,765 +12,482,656 +20% 11 Aug 2020 10-Q 17 Aug 2020 2020 Q2
Q1 2020 73,732,288 +26,440,930 +56% 27 Mar 2020 10-K 30 Mar 2020 2019 FY
Q3 2019 61,633,809 +14,342,451 +30% 12 Nov 2019 10-Q 12 Nov 2019 2019 Q3
Q2 2019 61,438,109 +14,146,751 +30% 06 Aug 2019 10-Q 08 Aug 2019 2019 Q2
Q1 2019 47,291,358 +13,901,948 +42% 15 Mar 2019 10-K 15 Mar 2019 2018 FY
Q3 2018 47,291,358 +13,904,376 +42% 09 Nov 2018 10-Q 09 Nov 2018 2018 Q3
Q2 2018 47,291,358 +15,940,024 +51% 07 Aug 2018 10-Q 09 Aug 2018 2018 Q2
Q1 2018 33,389,410 +10,754,697 +48% 15 Mar 2018 10-K 16 Mar 2018 2017 FY
Q3 2017 33,386,982 +11,802,149 +55% 14 Nov 2017 10-Q 14 Nov 2017 2017 Q3
Q2 2017 31,351,334 14 Aug 2017 10-Q 14 Aug 2017 2017 Q2
Q1 2017 22,634,713 +9,175,652 +68% 30 Mar 2017 10-K 30 Mar 2017 2016 FY
Q3 2016 21,584,833 +8,153,174 +61% 14 Nov 2016 10-Q 14 Nov 2016 2016 Q3
Q1 2016 13,459,061 +127,623 +0.96% 23 Mar 2016 10-K 23 Mar 2016 2015 FY
Q3 2015 13,431,659 +2,880,140 +27% 09 Nov 2015 10-Q 09 Nov 2015 2015 Q3
Q2 2015 13,431,223 +2,929,704 +28% 07 Aug 2015 10-Q 07 Aug 2015 2015 Q2
Q1 2015 13,331,438 26 Mar 2015 10-KT 26 Mar 2015 2014 FY
Q3 2014 10,551,519 -94,324,890 -90% 31 Oct 2014 10-Q 14 Nov 2014 2014 Q2
Q2 2014 10,501,519 -94,202,527 -90% 16 Jun 2014 10-K 23 Jun 2014 2014 FY
Q4 2013 10,469,987 -93,958,005 -90% 03 Feb 2014 10-Q 14 Feb 2014 2013 Q3
Q3 2013 104,876,409 +5,928,061 +6% 04 Nov 2013 10-Q 13 Nov 2013 2013 Q2
Q2 2013 104,704,046 +6,557,457 +6.7% 28 Jun 2013 10-K 03 Jul 2013 2012 FY
Q4 2012 104,427,992 +11,294,546 +12% 13 Feb 2013 10-Q 19 Feb 2013 2012 Q3
Q3 2012 98,948,348 09 Nov 2012 10-Q 13 Nov 2012 2012 Q2
Q2 2012 98,146,589 +10,262,630 +12% 27 Jun 2012 10-K 29 Jun 2012 2011 FY
Q4 2011 93,133,446 18 Nov 2011 10-Q 21 Nov 2011 2011 Q2
Q2 2011 87,883,959 31 Jul 2011 10-Q 15 Aug 2011 2011 Q1
* An asterisk sign (*) next to the value indicates that the value is likely invalid.